- FDA guides pharma on explaining unapproved drugs to payorsBiopharma companies preparing to launch the next practice-changing blockbusters want payors to know what's coming before they ultimately land an FDA approval. The trick is to do that without stretc…Endpoints · 1mo ago↗ source
- Legend surges on early data for ‘in vivo’ lymphoma cell therapy<figure><div><img src="https://imgproxy.divecdn.com/WrykHCObgQORJy6_Nsx19TUHTg8V8DEoa5UN1HcFlZc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTcxODMyMDY3LmpwZ…BioPharma Dive · 1mo ago↗ source
- What it will take for more employer GLP-1 coverageLast week, Eli Lilly proclaimed that its weight loss shot and pill are now “covered for millions of Americans,” now that all three major pharmacy benefit managers have put the ...